C. Bonomi

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
C A Bonomi, Carrie A. Bonomi, C Bonomi, Carrie A Bonomi, Carrie Bonomi
Publication record
36 papers · 686 citations · H-index 9

PAPERS

Abstract 6898: Cholangiocarcinoma patient-derived models in the NCI Patient-Derived Models Repository
20240 citationsauthor #5
Abstract 36: Comparing twenty-two matched patient-derived cell lines developed from either patient, PDX, or organoid tumor cell material
20230 citationsauthor #5
Abstract 5720: Combination therapies in matched 3D in vitro and in vivo preclinical models of rare and recalcitrant cancers from the National Cancer Institute’s Patient-Derived Models Repository
20230 citationsauthor #24
Abstract 40: NCI patient derived models repository: PDX, organoid and cell lines from the same patient - bridging the translational pipeline
20231 citationsauthor #5
Abstract 3120: Method development for generation of PDX models from rapid autopsy samples for the NCI patient-derived models repository
20220 citationsauthor #4
Abstract 3913: Evaluation of patient-derived cell lines and cancer organoids for the prediction of drug responses in patient-derived xenograft models
20200 citationsauthor #6
Abstract 3916: Patient-derived organoid and cell culture models from the NCI Patient-Derived Models Repository (NCI PDMR) preserve genomic stability and heterogeneity of patient tumor specimens
20201 citationsauthor #24
Abstract 3385: Comparison of genomic biomarkers identified by the whole exome, RNASeq and whole genome sequencing pipelines developed for the PDMR
20190 citationsauthor #15
Abstract 4524: Comparison of PDX, PDC, and PDOrg models from the National Cancer Institute’s Patient-Derived Models Repository (PDMR)
20191 citationsauthor #7
Abstract 986: The National Cancer Institute's patient-derived models repository (PDMR)
20183 citationsauthor #7
Abstract 1039: PDX models generated from a patient with metastatic colon adenocarcinoma display both spatial and temporal tumor heterogeneity
20180 citationsauthor #14
Abstract 4827: Establishing a platform for the generation of organoids from diverse tumor types as part of the NCI patient-derived models (PDM) initiave
20170 citationsauthor #4
Abstract 3840: The National Cancer Institute’s patient-derived models repository (PDMR)
20172 citationsauthor #7
Abstract 5139: Cell sorting strategies for the isolation of cancer cells and associated fibroblasts from tumor biopsies, surgical resections, and patient-derived xenografts
20150 citationsauthor #3
Abstract 3236: Clonal heterogeneity in patient-derived xenografts: The SCLC model LG0904F1496M23 contains stable clones with epithelial or mesenchymal characteristics and differential drug sensitivities
20150 citationsauthor #3
Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies
20140 citationsauthor #6
Generation of the rGH-ffLuc-eGFP (“Glowing Head”) genetically engineered mouse.
20140 citationsauthor #4
“Glowing Head” Mice: A Genetic Tool Enabling Reliable Preclinical Image-Based Evaluation of Cancers in Immunocompetent Allografts
201440 citationsauthor #4
Reporter activity and metastasis of ffLuc-eGFP-labeled cancer cells are consistent in GH mice but suppressed in immunocompetent wildtype mice.
20140 citationsauthor #4
Gene expression profiling of 49 human tumor xenografts from in vitro culture through multiple in vivo passages - strategies for data mining in support of therapeutic studies
201439 citationsauthor #6
Abstract 1556: Immunological naturalization of immunocompetent host mice to luciferase-GFP for consistent tracking of transplanted tumors.
20130 citationsauthor #4
Preclinical therapeutic response of residual metastatic disease is distinct from its primary tumor of origin
201232 citationsauthor #3
Abstract A9: Preclinical modeling of responses and resistance of residual metastatic disease to adjuvant chemotherapy
20100 citationsauthor #3
Lentivirus‐mediated bifunctional cell labeling for in vivo melanoma study
200950 citationsauthor #3
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition
2009167 citationsauthor #4
Evidence of in vivo efficacy for the indenoisoquinolines linked with pharmacodynamic markers for γH2AX
20074 citationsauthor #4
Synergistic antitumor activity of Bevacizumab in combination with HIF-1 inhibition.
20070 citationsauthor #7
Accelerated Preclinical Testing Using Transplanted Tumors from Genetically Engineered Mouse Breast Cancer Models
200754 citationsauthor #12
557 POSTER Effect of surgical tumor resection methods on expression of signaling molecules in mouse models
20060 citationsauthor #4
The importance of the pharmacology of luciferin and its effect on bioluminescent endpoints when conducting in vivo and in vitro experiments
20050 citationsauthor #1
Schedule-dependent Inhibition of Hypoxia-inducible Factor-1α Protein Accumulation, Angiogenesis, and Tumor Growth by Topotecan in U251-HRE Glioblastoma Xenografts
2004189 citationsauthor #6
The hollow fibre model in cancer drug screening: the NCI experience.
200467 citationsauthor #3
327 Schedule-dependent inhibition of HIF-1alpha protein accumulation, angiogenesis and tumor growth by topotecan in U251 glioblastoma xenografts
20040 citationsauthor #5
Advances in Brief Schedule-dependent Inhibition of Hypoxia-inducible Factor-1 Protein Accumulation , Angiogenesis , and Tumor Growth by Topotecan in U 251-HRE Glioblastoma Xenografts
20042 citationsauthor #6
A potential role for imaging technology in anticancer efficacy evaluations.
200435 citationsauthor #2
Comparison of arachidonic acid metabolism by normal, precancerous and neoplastic epithelial cell lines of the upper aerodigestive tract.
19970 citationsauthor #3

TIMELINE

1997 0 citations

2004 293 citations

2005 0 citations

2006 0 citations

2007 58 citations

2009 217 citations

2010 0 citations

2012 32 citations

2013 0 citations

2014 79 citations

2015 0 citations

2017 2 citations

2018 3 citations

2019 1 citations

2020 1 citations

2022 0 citations

2023 1 citations

2024 0 citations

C. Bonomi

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT